Literature DB >> 33007702

Test-retest reliability of DSM-5 substance disorder measures as assessed with the PRISM-5, a clinician-administered diagnostic interview.

Deborah Hasin1, Dvora Shmulewitz2, Malka Stohl3, Eliana Greenstein3, Stephanie Roncone3, Efrat Aharonovich2, Melanie Wall2.   

Abstract

AIM: In DSM-5, the definitions of substance use disorders (SUD) were changed considerably, yet little is known about the reliability of DSM-5 SUD and its new features.
METHODS: The test-retest reliability of DSM-5 SUD and DSM-IV substance dependence (SD) was evaluated in 565 adult substance users, each interviewed twice by different clinician interviewers using the semi-structured Psychiatric Research Interview for Substance and Mental Disorders, DSM-5 version (PRISM-5). DSM-5 SUD and DSM-IV SD criteria were assessed for past year and lifetime, yielding diagnoses and severity levels for alcohol, tobacco, cannabis, cocaine, heroin, opioids, sedatives, hallucinogen, and stimulant use disorders. Cohen's and intraclass correlation coefficients (ICC) assessed reliability for categorical and graded outcomes, respectively. Factors potentially influencing reliability were explored, including inpatient vs. community participant, days between interviews gender, age, race/ethnicity, and SUD severity.
RESULTS: DSM-5 SUD diagnoses had substantial to excellent reliability for most substances (κ = 0.63-0.94), and moderate for others (hallucinogens, stimulants, sedatives; κ = 0.50-0.59). For graded outcomes (DSM-5 SUD mild, moderate, severe; criteria count 0-11), reliability was substantial to excellent (ICC = 0.74-0.99). Comparisons of DSM-5 SUD and DSM-IV SD reliability showed few significant differences. Reliability of the DSM-5 craving criterion was excellent for heroin (κ = 0.84-0.95) and moderate to substantial for other substances (κ = 0.49-0.76). The only factor influencing reliability of SUD was severity, with milder disorders significantly more likely to be discordant between the interviews.
CONCLUSION: Reproducibility is crucial to good measurement. In a large sample using rigorous methodology, diagnoses and dimensional measures from clinician-administered interviews for DSM-5 SUD were generally highly reliable.
Copyright © 2020. Published by Elsevier B.V.

Entities:  

Keywords:  DSM-5; Dependence; Reliability; Substance use disorders; Test-restest

Mesh:

Year:  2020        PMID: 33007702      PMCID: PMC7663179          DOI: 10.1016/j.drugalcdep.2020.108294

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  47 in total

Review 1.  The measurement of drug craving.

Authors:  M A Sayette; S Shiffman; S T Tiffany; R S Niaura; C S Martin; W G Shadel
Journal:  Addiction       Date:  2000-08       Impact factor: 6.526

Review 2.  Review of the validity and significance of cannabis withdrawal syndrome.

Authors:  Alan J Budney; John R Hughes; Brent A Moore; Ryan Vandrey
Journal:  Am J Psychiatry       Date:  2004-11       Impact factor: 18.112

Review 3.  Intraclass correlations: uses in assessing rater reliability.

Authors:  P E Shrout; J L Fleiss
Journal:  Psychol Bull       Date:  1979-03       Impact factor: 17.737

4.  Inter-observer reliability of DSM-5 substance use disorders.

Authors:  Cécile M Denis; Joel Gelernter; Amy B Hart; Henry R Kranzler
Journal:  Drug Alcohol Depend       Date:  2015-05-27       Impact factor: 4.492

5.  Prescription opioid analgesic use among adults: United States, 1999-2012.

Authors:  Steven M Frenk; Kathryn S Porter; Leonard J Paulozzi
Journal:  NCHS Data Brief       Date:  2015-02

6.  Changes in the prevalence and correlates of cocaine use and cocaine use disorder in the United States, 2001-2002 and 2012-2013.

Authors:  Bradley T Kerridge; S Patricia Chou; Roger P Pickering; W June Ruan; Boji Huang; Jeesun Jung; Haitao Zhang; Amy Z Fan; Tulshi D Saha; Bridget F Grant; Deborah S Hasin
Journal:  Addict Behav       Date:  2018-11-07       Impact factor: 3.913

Review 7.  DSM-5 criteria for substance use disorders: recommendations and rationale.

Authors:  Deborah S Hasin; Charles P O'Brien; Marc Auriacombe; Guilherme Borges; Kathleen Bucholz; Alan Budney; Wilson M Compton; Thomas Crowley; Walter Ling; Nancy M Petry; Marc Schuckit; Bridget F Grant
Journal:  Am J Psychiatry       Date:  2013-08       Impact factor: 18.112

Review 8.  Changing landscape of cannabis: novel products, formulations, and methods of administration.

Authors:  Tory R Spindle; Marcel O Bonn-Miller; Ryan Vandrey
Journal:  Curr Opin Psychol       Date:  2019-04-09

9.  Epidemiology of DSM-5 Drug Use Disorder: Results From the National Epidemiologic Survey on Alcohol and Related Conditions-III.

Authors:  Bridget F Grant; Tulshi D Saha; W June Ruan; Risë B Goldstein; S Patricia Chou; Jeesun Jung; Haitao Zhang; Sharon M Smith; Roger P Pickering; Boji Huang; Deborah S Hasin
Journal:  JAMA Psychiatry       Date:  2016-01       Impact factor: 21.596

Review 10.  Alcohol use and burden for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.

Authors: 
Journal:  Lancet       Date:  2018-08-23       Impact factor: 202.731

View more
  6 in total

1.  Agreement between DSM-5 and DSM-IV measures of substance use disorders in a sample of adult substance users.

Authors:  Ofir Livne; Dvora Shmulewitz; Malka Stohl; Zachary Mannes; Efrat Aharonovich; Deborah Hasin
Journal:  Drug Alcohol Depend       Date:  2021-08-12       Impact factor: 4.492

2.  Test-retest reliability and cross-cultural applicability of DSM-5 adopted diagnostic criteria for ketamine use disorders.

Authors:  Nicole D Fitzgerald; Catherine W Striley; Joseph J Palamar; Jan Copeland; Steven Kurtz; Linda B Cottler
Journal:  Drug Alcohol Depend       Date:  2021-09-21       Impact factor: 4.492

3.  Validity of the DSM-5 craving criterion for alcohol, tobacco, cannabis, cocaine, heroin, and non-prescription use of prescription painkillers (opioids).

Authors:  D Shmulewitz; M Stohl; E Greenstein; S Roncone; C Walsh; E Aharonovich; M M Wall; D S Hasin
Journal:  Psychol Med       Date:  2021-11-01       Impact factor: 10.592

4.  Practical assessment of DSM-5 alcohol use disorder criteria in routine care: High test-retest reliability of an Alcohol Symptom Checklist.

Authors:  Kevin A Hallgren; Theresa E Matson; Malia Oliver; Ryan M Caldeiro; Daniel R Kivlahan; Katharine A Bradley
Journal:  Alcohol Clin Exp Res       Date:  2022-03       Impact factor: 3.455

5.  Correlates of mild, moderate, and severe Alcohol Use Disorder among adults with problem substance use: Validity implications for DSM-5.

Authors:  Zachary L Mannes; Dvora Shmulewitz; Ofir Livne; Malki Stohl; Deborah S Hasin
Journal:  Alcohol Clin Exp Res       Date:  2021-09-28       Impact factor: 3.928

6.  Validity of the DSM-5 tobacco use disorder diagnostics in adults with problematic substance use.

Authors:  Dvora Shmulewitz; Eliana Greenstein; Malka Stohl; David S Fink; Stephanie Roncone; Claire Walsh; Efrat Aharonovich; Deborah S Hasin
Journal:  Drug Alcohol Depend       Date:  2022-03-17       Impact factor: 4.852

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.